Bausch Health Companies INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Bausch Health Companies Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on May 19, 2026, to elect directors, approve executive compensation, and appoint auditors.
NYSE
Bausch Health Companies Inc. calls a Special Meeting for October 7, 2025, to ratify its recently adopted shareholder rights plan, aimed at ensuring fair treatment for all shareholders in potential take-over bids.
NYSE
Bausch Health Companies Inc. updates its proxy statement with revised information regarding the beneficial ownership of its common shares by Carl Icahn and Paulson & Co., Inc. in preparation for the 2025 Annual Meeting of Shareholders.
NYSE
Bausch Health Companies Inc. has filed a definitive proxy statement with the SEC, soliciting material pursuant to Section 240.14a-12.
NYSE
Bausch Health Companies Inc. announces its 2025 Annual Meeting of Shareholders to be held virtually on May 13, 2025, featuring proposals for director elections, executive compensation, and employee stock purchase plan approval.
NYSE
Bausch Health Companies Inc. has filed a definitive proxy statement with the SEC, related to its upcoming shareholder meeting.
NYSE
Bausch Health Companies Inc. is holding its 2024 Annual Meeting of Shareholders on May 14, 2024, to vote on key proposals including the election of directors, executive compensation, and an amendment to the company's incentive plan.